PILOT COMMERCIAL PRODUCTION LINE ESTABLISHED & $1.25M GRANT PAYMENT RECEIVED EMVision Medical Devices Limited (ASX:EMV) (“EMVision” or the “Company”) is pleased to advise that it has established its pilot commercial production line and received the final $1,250,000 non-dilutive cash payment under the Modern Manufacturing Initiative (MMI) grant program. EMVision was awarded $5 million in non-dilutive funding under the Federal Government's MMI Medical Products Translation stream to establish commercial production of EMVision's emu™ point-of-care brain scanner. The production line, at EMVision’s Macquarie Park premises, has an initial capacity for the build, test and release of approximately one emu™ brain scanner per week. With modest personnel additions, under its current configuration, the production line is anticipated to have capacity for the build, test and release of up to 3 emu™ brain scanner devices per week. Authorised for release by the Board of the Company.
EMV Price at posting:
$2.00 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)